EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis

Laura Barcutean iD, Smaranda Maier iD, Mihai Burai-Patrascu iD, Lenard Farczadi, Rodica Balasa

International Journal of Molecular Sciences · 11.03.2024 · 25 (6) · 3198

DOI: 10.3390/ijms25063198 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.03.2024. Verfasst von Laura Barcutean und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, University of Medicine, Pharmacy, Science and Technology "George Emil Palade" Targu Mures, 540142 Targu Mures, Mures, Romania. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Research, Innovation and Digitalization, CNCS - UEFISCDI, Ministry of Research, Innovation and Digitalization, CNCS–UEFISCDI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative central nervous system (CNS) disorder, characterized by focal inflammation, demyelination, irreversible axonal loss and neurodegeneration. The proposed mechanism involves auto-reactive T lymphocytes crossing the blood–brain barrier (BBB), contributing to inflammation and demyelination. Pro-inflammatory Th1 and Th17 lymphocytes are pivotal in MS pathogenesis, highlighting an imbalanced interaction with regulatory T cells. Dysbiosis in the gut microbiota, characterized by microbial imbalance is implicated in systemic inflammation, yet its exact role in MS remains elusive. Short-chain fatty acids (SCFAs), including valerate, butyrate, propionate, and acetate, produced through dietary fiber fermentation by the gut microbiota, modulate inflammation and immune responses. Particularly, butyrate and propionate exhibit pronounced anti-inflammatory effects in both the gut and CNS. These SCFAs influence regulatory T lymphocyte expression and BBB permeability. This review discusses the potential therapeutic implications of SCFA in MS, highlighting their ability to modulate the gut–brain axis and restore immune balance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansPropionatesFatty Acids, VolatileButyratesInflammationImmunity

Stichwörter der Autor:innen

acetatebutyratemicrobiomemicrobiotamultiple sclerosispropionateshort-chain fatty acidsvalerate

Substanzen

PropionatesFatty Acids, VolatileButyrates

Autor:innen und Institutionen

  • Neurology Department, University of Medicine, Pharmacy, Science and Technology "George Emil Palade" Targu Mures, 540142 Targu Mures, Mures, Romania.
  • Molecular Forecaster Inc., Montreal, QC H3A 2L1, Canada.
  • Center for Advanced Medical and Pharmaceutical Research, University of Medicine, Pharmacy, Science, and Technology "George Emil Palade" Targu Mures, 540142 Targu Mures, Mures, Romania.

ORCID-Profile: Laura Barcutean, Smaranda Maier, Mihai Burai-Patrascu

Förderung

  • Ministry of Research, Innovation and Digitalization, CNCS - UEFISCDI
  • Ministry of Research, Innovation and Digitalization, CNCS–UEFISCDI

Zitieren

APA

Barcutean, L., Maier, S., Burai-Patrascu, M., Farczadi, L., & Balasa, R. (2024). The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis. International Journal of Molecular Sciences, 25(6), 3198. https://doi.org/10.3390/ijms25063198

Vancouver

Barcutean L, Maier S, Burai-Patrascu M, Farczadi L, Balasa R. The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis. International Journal of Molecular Sciences. 2024;25(6):3198. doi:10.3390/ijms25063198

BibTeX
@article{Barcutean2024,
  author = {Barcutean, Laura and Maier, Smaranda and Burai-Patrascu, Mihai and Farczadi, Lenard and Balasa, Rodica},
  title = {The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {6},
  pages = {3198},
  doi = {10.3390/ijms25063198}
}
Kostenlos starten →